In the following video, contributor Maxxwell Chatsko updates investors on Solazyme's (NASDAQ:TVIA) huge cash position. When the developmental stage company released first-quarter earnings earlier this month, investors learned that cash and cash equivalents stood at $239 million. That may not be a large sum of money for other companies, but it can go a long way for Solazyme as it builds out commercial scale.

The company is still pretty far away from reaching its targeted capacity additions over the next several years. Solazyme will have a global operational capacity of just over 125,000 metric tons by mid-2015, with an additional 325,000 metric tons of capacity on the way in the next several years. Investors are right to enjoy the cash hoard at the company, but should remember that substantially more money will be needed in the next few years.